Abstract
Natural products and their related compounds have been dominating as therapeutic agents for ages. Among them, numerous plant metabolites have made their way as drugs or drug precursors, thereby making them a “biosynthetic laboratory.” These phytochemical compounds extracted from different sources serve a myriad of physiological effects, eventually giving them the therapeutic properties we seek. The preliminary studies on any novel plant-based drug compounds involve different approaches like traditional, random, ethnopharmacology, and zoo-pharmacognosy. Recent advancements in genomics and proteomics have also helped us to understand various proteins targeted by plant metabolites. Despite of all the setbacks in natural drug application, copious phytomedicines have already made their way into clinical trials for various diseases. This chapter attempts to elucidate several plant metabolites as drug molecules with a focus on their screening, based on druglikeness features and properties. This integrated approach would save cost and time and in parallel enhance the rate of a successful drug discovery.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Abrecht S, Harrington P, Iding H, Karpf M, Trussardi R, Wirz B, Zutter U (2004) The synthetic development of the anti-influenza neuraminidase inhibitor oseltamivir phosphate (Tamiflu®): a challenge for synthesis & process research. Chimia 58:621–629
Akhtar MS, Swamy MK (2018) Anticancer plants: properties and application. Springer, Singapore
Alves-Silva JM, Romane A, Efferth T, Salgueiro L (2017) North African medicinal plants traditionally used in cancer therapy. Front Pharmacol 8:383
Bevan S (1999) Capsaicin and pain mechanisms. In: Brain SD, Moore PK (eds) Pain and neurogenic inflammation. Springer, Berlin, pp 61–80
Bilia AR, Gallori S, Vincieri FF (2002) St. John’s wort and depression: efficacy, safety and tolerability-an update. Life Sci 70:3077–3096
Bisset NG (1989) Arrow and dart poisons. J Ethnopharmacol 25:1–41
Borchardt JK (2002) The beginnings of drug therapy: ancient mesopotamian medicine. Drug News Perspect 15:187–192
Chernov L, Deyell RJ, Anantha M, Dos Santos N, Gilabert-Oriol R, Bally MB (2017) Optimization of liposomal topotecan for use in treating neuroblastoma. Cancer Med 6:1240–1254
Chua HC, Christensen ET, Hoestgaard-Jensen K, Hartiadi LY, Ramzan I, Jensen AA, Absalom NL, Chebib M (2016) Kavain, the major constituent of the anxiolytic kava extract, potentiates GABAA receptors: functional characteristics and molecular mechanism. PLoS One 11:e0157700
Cichewicz RH, Kouzi SA (2004) Chemistry, biological activity, and chemotherapeutic potential of betulinic acid for the prevention and treatment of cancer and HIV infection. Med Res Rev 24:90–114
Cragg GM, Newman DJ (2005) Biodiversity: a continuing source of novel drug leads. Pure Appl Chem 77:7–24
D’Arcy P, Griffin J (1995) Interactions with drugs used in the treatment of depressive illness. Adverse Drug React Toxicol Rev 14:211–231
Egan WJ, Merz KM, Baldwin JJ (2000) Prediction of drug absorption using multivariate statistics. J Med Chem 43:3867–3877
Enioutina EY, Salis ER, Job KM, Gubarev MI, Krepkova LV, Sherwin CM (2017) Herbal medicines: challenges in the modern world. Part 5. Status and current directions of complementary and alternative herbal medicine worldwide. Exp Rev Clin Pharmacol 10:327–338
Escamilla-García E, Alcázar-Pizaña A, Segoviano-Ramírez J, Angel-Mosqueda D, López-Lozano A, Cárdenas-Estrada E, La Garza-Ramos D, Márquez M (2017) Antimicrobial activity of a cationic guanidine compound against two pathogenic oral bacteria. Int J Microbiol 2017:5924717. https://doi.org/10.1155/2017/5924717
Fulda S, Debatin KM (2006) Resveratrol modulation of signal transduction in apoptosis and cell survival: a mini-review. Cancer Detect Prev 30:217–223
Ghose AK, Viswanadhan VN, Wendoloski JJ (1999) A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. J Comb Chem 1:55–68
Guo Z (2017) The modification of natural products for medical use. Acta Pharma Sinica B 7:119–136
Hall MG, Wilks MF, Provan WM, Eksborg S, Lumholtz B (2001) Pharmacokinetics and pharmacodynamics of NTBC (2-(2-nitro-4-fluoromethylbenzoyl)-1,3-cyclohexane- dione) and mesotrione, inhibitors of 4-hydroxyphenyl pyruvate dioxygenase (HPPD) following a single dose to healthy male volunteers. Br J Clin Pharmacol 52:169–177
Harborne A (1998) Phytochemical methods a guide to modern techniques of plant analysis. Springer, Dordrecht
Hull CM, Warrilow AG, Rolley NJ, Price CL, Donnison IS, Kelly DE, Kelly SL (2017) Co-production of 11α-hydroxyprogesterone and ethanol using recombinant yeast expressing fungal steroid hydroxylases. Biotechnol Biofuels 10:226
Jung S, Kim MH, Park JH, Jeong Y, Ko KS (2017) Cellular antioxidant and anti-inflammatory effects of coffee extracts with different roasting levels. J Med Food 20:626–635
Kamsteeg M, Rutherford T, Sapi E, Hanczaruk B, Shahabi S, Flick M, Brown D, Mor G (2003) Phenoxodiol–an isoflavone analog–induces apoptosis in chemoresistant ovarian cancer cells. Oncogene 22:2611
Kapoor L (2017) Handbook of Ayurvedic medicinal plants: herbal reference library. Routledge, Abingdon
Katiyar C, Gupta A, Kanjilal S, Katiyar S (2012) Drug discovery from plant sources: an integrated approach. Ayu 33:10
Koehn FE, Carter GT (2005) The evolving role of natural products in drug discovery. Nat Rev Drug Disc 4:206
Krentz AJ, Bailey CJ (2005) Oral antidiabetic agents. Drugs 65:385–411
Lee KH, Xiao Z (2005) Podophyllotoxins and analogs. In: Cragg GM, Kingston DGI, Newman DJ (eds) Anticancer agents from natural products. CRC Press, Boca Raton, pp 71–88
Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings1. Adv Drug Del Rev 46:3–26
Maki C, Funakoshi-Tago M, Aoyagi R, Ueda F, Kimura M, Kobata K, Tago K, Tamura H (2017) Coffee extract inhibits adipogenesis in 3T3-L1 preadipocyes by interrupting insulin signaling through the downregulation of IRS1. PLoS One 12:e0173264
Mann J (2000) Murder, magic, and medicine. Oxford University Press, Oxford
Mihalak KB, Carroll FI, Luetje CW (2006) Varenicline is a partial agonist at α4β2 and a full agonist at α7 neuronal nicotinic receptors. Mol Pharmacol 70:801–805
Muegge I, Heald SL, Brittelli D (2001) Simple selection criteria for drug-like chemical matter. J Med Chem 44:1841–1846
Nerurkar PV, Dragull K, Tang CS (2004) In vitro toxicity of kava alkaloid, pipermethystine, in HepG2 cells compared to kavalactones. Toxicol Sci 79:106–111
Nunn JF (2002) Ancient egyptian medicine. University of Oklahoma Press, Oklahoma
Oguzkan SB, Karagul B, Uzun A, Guler OO, Ugras HI (2018) Pre-purification of an anticancer drug (paclitaxel) obtained from nut husks. Int J Pharmacol 14:76–82
Pinney KG, Jelinek C, Edvardsen K, Chaplin D, Pettit G (2005) The discovery and development of the combretastatins. In: Cragg GM, Kingston DGI, Newman DJ (eds) Anticancer agents from natural products. CRC Press, Boca Raton, pp 23–46
Rahier NJ, Thomas CJ, Hecht SM (2005) Camptothecin and its analogs. In: Cragg GM, Kingston DGI, Newman DJ (eds) Anticancer agents from natural products. CRC Press, Boca Raton, pp 5–22
Ravichandra V, Ramesh C, Swamy MK, Purushotham B, Rudramurthy GR (2018) Anticancer plants: chemistry, pharmacology, and potential applications. In: Akhtar MS, Swamy MK (eds) Anticancer plants: properties and application, vol 1. Springer Nature, Singapore, pp 485–515
Ritter S (2004) Green innovations. Chem Eng News 82:25–30
Rowe A, Ramzan I (2012) Are mould hepatotoxins responsible for kava hepatotoxicity. Phytother Res 26:1768–1770
Salim A, Chin YW, Douglas Kinghorn A (2008) Drug discovery from plants. In: Ramawat K, Merillon J (eds) Bioactive molecules and medicinal plants. Springer, Berlin, Heidelberg
Sanagapalli S, Agnihotri K, Leong R, Corte CJ (2017) Antispasmodic drugs in colonoscopy: a review of their pharmacology, safety and efficacy in improving polyp detection and related outcomes. Ther Adv Gastroenterol 10:101–113
Shin JS, Ku KB, Jang Y, Yoon YS, Shin D, Kwon OS, Go YY, Kim SS, Bae MA, Kim M (2017) Comparison of anti-influenza virus activity and pharmacokinetics of oseltamivir free base and oseltamivir phosphate. J Microbiol 55:979–983
Slezakova S, Ruda-Kucerova J (2017) Anticancer activity of artemisinin and its derivatives. Anticancer Res 37:5995–6003
Smith KK, Dharmaratne HRW, Feltenstein MW, Broom SL, Roach JT, Nanayakkara ND, Khan IA, Sufka KJ (2001) Anxiolytic effects of kava extract and kavalactones in the chick social separation-stress paradigm. Psychopharmacology 155:86–90
Sneader W (1996) Drug prototypes and their exploitation. Wiley, Chichester
Sneader W (2005) Drug discovery: a history. John Wiley and Sons, Chichester
Stermitz FR, Lorenz P, Tawara JN, Zenewicz LA, Lewis K (2000) Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump inhibitor. Proc Natl Acad Sci U S A 97:1433–1437
Szallasi A, Appendino G (2004) Vanilloid receptor TRPV1 antagonists as the next generation of painkillers. Are we putting the cart before the horse. J Med Chem 47:2717–2723
Tabata H (2004) Paclitaxel production by plant-cell-culture technology. In: Zhong JJ (ed) Biomanufacturing. Advances in biochemical engineering, vol 87. Springer, Berlin/Heidelberg, pp 1–23
Tariq A, Sadia S, Pan K, Ullah I, Mussarat S, Sun F, Abiodun OO, Batbaatar A, Li Z, Song D (2017) A systematic review on ethnomedicines of anti-cancer plants. Phytother Res 31:202–264
Tayyab Ansari M, Saeed Saify Z, Sultana N, Ahmad I, Saeed-Ul-Hassan S, Tariq I, Khanum M (2013) Malaria and artemisinin derivatives: an updated review. Mini Rev Med Chem 13:1879–1902
Tewari D, Mocan A, Parvanov ED, Sah AN, Nabavi SM, Huminiecki L, Ma ZF, Lee YY, Horbańczuk JO, Atanasov AG (2017) Ethnopharmacological approaches for therapy of jaundice: part II. Highly used plant species from Acanthaceae, Euphorbiaceae, Asteraceae, Combretaceae, and Fabaceae families. Front Pharmacol 8:519
Van Wyk B, Wink M (2015) Phytomedicines, herbal drugs and poisons. Kew Publishing/Cambridge University Press, Briza/Cambridge
Veber DF, Johnson SR, Cheng H-Y, Smith BR, Ward KW, Kopple KD (2002) Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem 45:2615–2623
Wall M (1960) Steroidal sapogenins and derived steroid hormones. Am Perfumer Aromat 76:63–73
Wink M (2015) Modes of action of herbal medicines and plant secondary metabolites. Medicines 2:251–286
Yao H, Liu J, Xu S, Zhu Z, Xu J (2017) The structural modification of natural products for novel drug discovery. Expert Opin Drug Discovery 12:121–140
Yarnell A (2005) Organic chemistry-meeting delivers organic feast. Chem Eng News 83:22–23
Yeung Y-Y, Hong S, Corey EJ (2006) A short enantioselective pathway for the synthesis of the anti-influenza neuramidase inhibitor oseltamivir from 1, 3-butadiene and acrylic acid. J Am Chem Soc 128:6310–6311
Yogeeswari P, Sriram D (2005) Betulinic acid and its derivatives: a review on their biological properties. Curr Med Chem 12:657–666
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Sasidharan, S., Saudagar, P. (2019). Plant Metabolites as New Leads to Drug Discovery. In: Swamy, M., Akhtar, M. (eds) Natural Bio-active Compounds. Springer, Singapore. https://doi.org/10.1007/978-981-13-7205-6_12
Download citation
DOI: https://doi.org/10.1007/978-981-13-7205-6_12
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-7204-9
Online ISBN: 978-981-13-7205-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)